Literature DB >> 10556572

Role of disulfide bridges in the folding, structure and biological activity of omega-conotoxin GVIA.

J P Flinn1, P K Pallaghy, M J Lew, R Murphy, J A Angus, R S Norton.   

Abstract

Omega-Conotoxin GVIA (GVIA), an N-type calcium channel blocker from the cone shell Conus geographus, is a 27 residue polypeptide cross-linked by three disulfide bonds. Here, we report the synthesis, structural analysis by (1)H NMR and bioassay of analogues of GVIA with disulfide bridge deletions and N- and C-terminal truncations. Two analogues that retain the crucial Lys-2 and Tyr-13 residues in loops constrained by two native disulfide bridges were synthesised using orthogonal protection of cysteine residues. In the first analogue, the Cys-15-Cys-26 disulfide bridge was deleted (by replacing the appropriate Cys residues with Ser), while in the second, this disulfide bridge and the eight C-terminal residues were deleted. No activity was detected for either analogue in a rat vas deferens assay, which measures N-type calcium channel activity in sympathetic nerve, and NMR studies showed that this was due to a gross loss of secondary and tertiary structure. Five inactive analogues that were synthesised without orthogonal protection of Cys residues as part of a previous study (Flinn et al. (1995) J. Pept. Sci. 1, 379-384) were also investigated. Three had single disulfide deletions (via Ser substitutions) and two had N- or C-terminal deletions in addition to the disulfide deletion. Peptide mapping and NMR analyses demonstrated that at least four of these analogues had non-native disulfide pairings, which presumably accounts for their lack of activity. The NMR studies also showed that all five analogues had substantially altered tertiary structures, although the backbone chemical shifts and nuclear Overhauser enhancements (NOEs) implied that native-like turn structures persisted in some of these analogues despite the non-native disulfide pairings. This work demonstrates the importance of the disulfides in omega-conotoxin folding and shows that the Cys-15-Cys-26 disulfide is essential for activity in GVIA. The NMR analyses also emphasise that backbone chemical shifts and short- and medium-range NOEs are dictated largely by local secondary structure elements and are not necessarily reliable monitors of the tertiary fold.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556572     DOI: 10.1016/s0167-4838(99)00165-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

Review 1.  Calcium channel blockers and pain therapy.

Authors:  B Cox
Journal:  Curr Rev Pain       Date:  2000

2.  t-boc synthesis of huwentoxin-i through native chemical ligation incorporating a trifluoromethanesulfonic acid cleavage strategy.

Authors:  Parashar Thapa; Chino C Cabalteja; Edwin E Philips; Michael J Espiritu; Steve Peigneur; Bea G Mille; Jan Tytgat; Theodore R Cummins; Jon-Paul Bingham
Journal:  Biopolymers       Date:  2016-09       Impact factor: 2.505

Review 3.  Early engineering approaches to improve peptide developability and manufacturability.

Authors:  Jennifer L Furman; Mark Chiu; Michael J Hunter
Journal:  AAPS J       Date:  2014-10-23       Impact factor: 4.009

4.  Dissecting a role of evolutionary-conserved but noncritical disulfide bridges in cysteine-rich peptides using ω-conotoxin GVIA and its selenocysteine analogs.

Authors:  Konkallu Hanumae Gowd; Kirk D Blais; Keith S Elmslie; Andrew M Steiner; Baldomero M Olivera; Grzegorz Bulaj
Journal:  Biopolymers       Date:  2012       Impact factor: 2.505

5.  Structure of the analgesic mu-conotoxin KIIIA and effects on the structure and function of disulfide deletion.

Authors:  Keith K Khoo; Zhi-Ping Feng; Brian J Smith; Min-Min Zhang; Doju Yoshikami; Baldomero M Olivera; Grzegorz Bulaj; Raymond S Norton
Journal:  Biochemistry       Date:  2009-02-17       Impact factor: 3.162

6.  Structure of conkunitzin-S1, a neurotoxin and Kunitz-fold disulfide variant from cone snail.

Authors:  Catherine Y Dy; Pawel Buczek; Julita S Imperial; Grzegorz Bulaj; Martin P Horvath
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2006-08-19

7.  Structurally minimized mu-conotoxin analogues as sodium channel blockers: implications for designing conopeptide-based therapeutics.

Authors:  Tiffany S Han; Min-Min Zhang; Aleksandra Walewska; Pawel Gruszczynski; Charles R Robertson; Thomas E Cheatham; Doju Yoshikami; Baldomero M Olivera; Grzegorz Bulaj
Journal:  ChemMedChem       Date:  2009-03       Impact factor: 3.466

8.  Cyclic analogues of α-conotoxin Vc1.1 inhibit colonic nociceptors and provide analgesia in a mouse model of chronic abdominal pain.

Authors:  Joel Castro; Luke Grundy; Annemie Deiteren; Andrea M Harrington; Tracey O'Donnell; Jessica Maddern; Jessi Moore; Sonia Garcia-Caraballo; Grigori Y Rychkov; Rilei Yu; Quentin Kaas; David J Craik; David J Adams; Stuart M Brierley
Journal:  Br J Pharmacol       Date:  2018-02-13       Impact factor: 8.739

Review 9.  Arginine-dependent immune responses.

Authors:  Adrià-Arnau Martí I Líndez; Walter Reith
Journal:  Cell Mol Life Sci       Date:  2021-05-26       Impact factor: 9.261

Review 10.  Discovery, synthesis, and structure-activity relationships of conotoxins.

Authors:  Kalyana B Akondi; Markus Muttenthaler; Sébastien Dutertre; Quentin Kaas; David J Craik; Richard J Lewis; Paul F Alewood
Journal:  Chem Rev       Date:  2014-04-10       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.